About
Who We Are
Serimmune is an immune intelligence company focused on identifying and exploiting the universe of relationships between antibodies and antigens. Our proprietary technology provides a holistic view of the circulating antibody repertoire to identify diverse immunogenic factors in disease and health. Serimmune’s human immunity map is a growing database that can be interrogated to fuel the development of multiplex diagnostics, vaccines and therapeutics.
Leadership
Malek Faham, MD, PhD
Chief Executive Officer
John Shon, MD, MS
Chief Technology Officer
Heidi Smith
VP, Finance & Controller
Rocco Raduazo, MBA
VP, Business Development
Kathy Kamath, PhD
Sr. Director, R&D
Jack Reifert, PhD
Sr. Director, R&D/Operations
Board of Directors
Nick Naclerio, PhD
Founding Partner, Illumina Ventures
Bill Welch, MBA
Partner, Illumina Ventures
Kristin Loomis, MBA
President & Executive Director,
HHV-6 Foundation
Patrick Daugherty, PhD
Founder & CSO, Serimmune
Scientific Advisory Board
Elitza Theel, PhD
Mayo Clinic
Felix Feng, MD
UCSF
Anthony Komaroff, MD
BWH Harvard
Anshul Kundaje, PhD
Stanford
Patrick Daugherty, PhD
UCSB (Faculty alum)
Gary Schroth, PhD
Illumina